Literature DB >> 23334171

Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses.

Maral Yolamanova1, Christoph Meier, Alexey K Shaytan, Virag Vas, Carlos W Bertoncini, Franziska Arnold, Onofrio Zirafi, Shariq M Usmani, Janis A Müller, Daniel Sauter, Christine Goffinet, David Palesch, Paul Walther, Nadia R Roan, Hartmut Geiger, Oleg Lunov, Thomas Simmet, Jens Bohne, Hubert Schrezenmeier, Klaus Schwarz, Ludger Ständker, Wolf-Georg Forssmann, Xavier Salvatella, Pavel G Khalatur, Alexei R Khokhlov, Tuomas P J Knowles, Tanja Weil, Frank Kirchhoff, Jan Münch.   

Abstract

Inefficient gene transfer and low virion concentrations are common limitations of retroviral transduction. We and others have previously shown that peptides derived from human semen form amyloid fibrils that boost retroviral gene delivery by promoting virion attachment to the target cells. However, application of these natural fibril-forming peptides is limited by moderate efficiencies, the high costs of peptide synthesis, and variability in fibril size and formation kinetics. Here, we report the development of nanofibrils that self-assemble in aqueous solution from a 12-residue peptide, termed enhancing factor C (EF-C). These artificial nanofibrils enhance retroviral gene transfer substantially more efficiently than semen-derived fibrils or other transduction enhancers. Moreover, EF-C nanofibrils allow the concentration of retroviral vectors by conventional low-speed centrifugation, and are safe and effective, as assessed in an ex vivo gene transfer study. Our results show that EF-C fibrils comprise a highly versatile, convenient and broadly applicable nanomaterial that holds the potential to significantly facilitate retroviral gene transfer in basic research and clinical applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23334171     DOI: 10.1038/nnano.2012.248

Source DB:  PubMed          Journal:  Nat Nanotechnol        ISSN: 1748-3387            Impact factor:   39.213


  29 in total

Review 1.  Structures for amyloid fibrils.

Authors:  O Sumner Makin; Louise C Serpell
Journal:  FEBS J       Date:  2005-12       Impact factor: 5.542

2.  Self-assembling nanofibers from thiophene-peptide diblock oligomers: a combined experimental and computer simulations study.

Authors:  Alexey K Shaytan; Eva-Kathrin Schillinger; Pavel G Khalatur; Elena Mena-Osteritz; Jens Hentschel; Hans G Börner; Peter Bäuerle; Alexei R Khokhlov
Journal:  ACS Nano       Date:  2011-08-16       Impact factor: 15.881

3.  Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells.

Authors:  H Hanenberg; K Hashino; H Konishi; R A Hock; I Kato; D A Williams
Journal:  Hum Gene Ther       Date:  1997-12-10       Impact factor: 5.695

4.  Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells.

Authors:  H Hanenberg; X L Xiao; D Dilloo; K Hashino; I Kato; D A Williams
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

5.  Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.

Authors:  Axel Schambach; Jens Bohne; Saurabh Chandra; Elke Will; Geoffrey P Margison; David A Williams; Christopher Baum
Journal:  Mol Ther       Date:  2005-10-12       Impact factor: 11.454

6.  Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

Authors:  Virginie Sandrin; Bertrand Boson; Patrick Salmon; Wilfried Gay; Didier Nègre; Roger Le Grand; Didier Trono; François-Loïc Cosset
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

7.  Role of intermolecular forces in defining material properties of protein nanofibrils.

Authors:  Tuomas P Knowles; Anthony W Fitzpatrick; Sarah Meehan; Helen R Mott; Michele Vendruscolo; Christopher M Dobson; Mark E Welland
Journal:  Science       Date:  2007-12-21       Impact factor: 47.728

8.  The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.

Authors:  Nadia R Roan; Jan Münch; Nathalie Arhel; Walther Mothes; Jason Neidleman; Akiko Kobayashi; Karen Smith-McCune; Frank Kirchhoff; Warner C Greene
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

Review 9.  Human myeloid leukemia cell lines: a review.

Authors:  H P Koeffler; D W Golde
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

10.  Semen-derived amyloid fibrils drastically enhance HIV infection.

Authors:  Jan Münch; Elke Rücker; Ludger Ständker; Knut Adermann; Christine Goffinet; Michael Schindler; Steffen Wildum; Raghavan Chinnadurai; Devi Rajan; Anke Specht; Guillermo Giménez-Gallego; Pedro Cuevas Sánchez; Douglas M Fowler; Atanas Koulov; Jeffery W Kelly; Walther Mothes; Jean-Charles Grivel; Leonid Margolis; Oliver T Keppler; Wolf-Georg Forssmann; Frank Kirchhoff
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

View more
  36 in total

1.  Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides.

Authors:  Onofrio Zirafi; Kyeong-Ae Kim; Nadia R Roan; Silvia F Kluge; Janis A Müller; Shibo Jiang; Benjamin Mayer; Warner C Greene; Frank Kirchhoff; Jan Münch
Journal:  Sci Transl Med       Date:  2014-11-12       Impact factor: 17.956

2.  Seminal plasma and semen amyloids enhance cytomegalovirus infection in cell culture.

Authors:  Qiyi Tang; Nadia R Roan; Yasuhiro Yamamura
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Designed amyloid fibers as materials for selective carbon dioxide capture.

Authors:  Dan Li; Hiroyasu Furukawa; Hexiang Deng; Cong Liu; Omar M Yaghi; David S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

4.  Tunable assembly of amyloid-forming peptides into nanosheets as a retrovirus carrier.

Authors:  Bin Dai; Dan Li; Wenhui Xi; Fang Luo; Xiang Zhang; Man Zou; Mi Cao; Jun Hu; Wenyuan Wang; Guanghong Wei; Yi Zhang; Cong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

5.  Cryo-EM reveals the steric zipper structure of a light chain-derived amyloid fibril.

Authors:  Andreas Schmidt; Karthikeyan Annamalai; Matthias Schmidt; Nikolaus Grigorieff; Marcus Fändrich
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

6.  Peptides derived from evolutionarily conserved domains in Beclin-1 and Beclin-2 enhance the entry of lentiviral vectors into human cells.

Authors:  Saliha Majdoul; Jeremie Cosette; Ababacar K Seye; Eric Bernard; Sophie Frin; Nathalie Holic; Nathalie Chazal; Laurence Briant; Lucile Espert; Anne Galy; David Fenard
Journal:  J Biol Chem       Date:  2017-09-19       Impact factor: 5.157

7.  Concurrent measures of fusion and transduction efficiency of primary CD34+ cells with human immunodeficiency virus 1-based lentiviral vectors reveal different effects of transduction enhancers.

Authors:  Dina Ingrao; Saliha Majdoul; Ababacar K Seye; Anne Galy; David Fenard
Journal:  Hum Gene Ther Methods       Date:  2013-11-20       Impact factor: 2.396

Review 8.  Structure, function and antagonism of semen amyloids.

Authors:  Annika Röcker; Nadia R Roan; Jay Kant Yadav; Marcus Fändrich; Jan Münch
Journal:  Chem Commun (Camb)       Date:  2018-07-05       Impact factor: 6.222

9.  A molecular tweezer antagonizes seminal amyloids and HIV infection.

Authors:  Edina Lump; Laura M Castellano; Christoph Meier; Janine Seeliger; Nelli Erwin; Benjamin Sperlich; Christina M Stürzel; Shariq Usmani; Rebecca M Hammond; Jens von Einem; Gisa Gerold; Florian Kreppel; Kenny Bravo-Rodriguez; Thomas Pietschmann; Veronica M Holmes; David Palesch; Onofrio Zirafi; Drew Weissman; Andrea Sowislok; Burkhard Wettig; Christian Heid; Frank Kirchhoff; Tanja Weil; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Elsa Sanchez-Garcia; Roland Winter; James Shorter; Jan Münch
Journal:  Elife       Date:  2015-08-18       Impact factor: 8.140

10.  Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.

Authors:  Laura M Castellano; Stephen M Bart; Veronica M Holmes; Drew Weissman; James Shorter
Journal:  Chem Biol       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.